EUVIMEDEUVIMED entdecken
Fallbericht

Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report

Siham Rouf, Khadija Boujtat, Tijani El Harroudi, Hanane Latrech

Int. Journal of Clinical Pharmacology and Therapeutics · 01.06.2024 · 62 (06) · 278-283

DOI: 10.5414/cp204503 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.06.2024. Verfasst von Siham Rouf und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Everolimus, Insulinoma, Pancreatic Neoplasms, Hypoglycemia. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EverolimusInsulinomaPancreatic NeoplasmsHypoglycemiaHumansFemaleMiddle AgedAntineoplastic AgentsLiver NeoplasmsBlood GlucoseFatal OutcomeDiazoxideTreatment Outcome

Substanzen

EverolimusAntineoplastic AgentsBlood GlucoseDiazoxide

Zitieren

APA

Rouf, S., Boujtat, K., El Harroudi, T., & Latrech, H. (2024). Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report. Int. Journal of Clinical Pharmacology and Therapeutics, 62(06), 278-283. https://doi.org/10.5414/cp204503

Vancouver

Rouf S, Boujtat K, El Harroudi T, Latrech H. Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report. Int. Journal of Clinical Pharmacology and Therapeutics. 2024;62(06):278-283. doi:10.5414/cp204503

BibTeX
@article{Rouf2024,
  author = {Rouf, Siham and Boujtat, Khadija and El Harroudi, Tijani and Latrech, Hanane},
  title = {Balancing efficacy and adverse reactions using everolimus in a patient with metastatic malignant insulinoma: Case report},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2024},
  volume = {62},
  number = {06},
  pages = {278--283},
  doi = {10.5414/cp204503}
}
Kostenlos starten →